Category: Dkoding

BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES

By DKODING Business Wire India Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered antibodies may allow for specific targeting of tumor cells without binding to healthy cells This partnership allows Boehringer Ingelheim to strengthen its tumor cell-directed Antibody-Drug Conjugate (ADC) and […]

Nicox: 2022 Extraordinary Shareholder Meeting

By DKODING Press Release Nicox: 2022 Extraordinary Shareholder Meeting June 3, 2022 – release at 8:30 am CETSophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, convenes an extraordinary shareholder meeting on Monday July 11, 2022 at 2:00 pm CEST in the offices of BuroClub – Drakkar 2 – Bâtiment D […]